Janneke A Wilschut

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Cancer Causes Control 21:2287-93. 2010
  2. ncbi How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cancer 117:4166-74. 2011
  3. ncbi Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Gastroenterology 141:1648-55.e1. 2011
  4. ncbi Fecal occult blood testing when colonoscopy capacity is limited
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 103:1741-51. 2011
  5. ncbi Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance
    Aafke H C van Roon
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Gastroenterol Hepatol 9:333-9. 2011
  6. ncbi Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis
    Iris Lansdorp-Vogelaar
    Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Intern Med 153:368-77. 2010

Collaborators

Detail Information

Publications6

  1. ncbi Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Cancer Causes Control 21:2287-93. 2010
    ..Our aim is to estimate the relative difference in adenoma prevalence and its age-pattern in individuals with a family history of colorectal cancer compared to those without...
  2. ncbi How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cancer 117:4166-74. 2011
    ..The authors investigated optimal screening strategies for individuals with various degrees of family history of CRC based on a cost-effectiveness analysis...
  3. ncbi Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Gastroenterology 141:1648-55.e1. 2011
    ..We aimed to identify the most cost-effective FIT cutoff level for referral to colonoscopy based on data from these trials and allowing for differences in screening ages...
  4. ncbi Fecal occult blood testing when colonoscopy capacity is limited
    Janneke A Wilschut
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 103:1741-51. 2011
    ..Which of these options is most clinically effective and cost-effective has yet to be established...
  5. ncbi Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance
    Aafke H C van Roon
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Clin Gastroenterol Hepatol 9:333-9. 2011
    ..There are not much data on the optimal number of FITs to perform. We conducted a population-based trial to determine attendance and diagnostic yield of 1- and 2-sample FIT screening...
  6. ncbi Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis
    Iris Lansdorp-Vogelaar
    Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Intern Med 153:368-77. 2010
    ..The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees...